These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37656169)

  • 1. Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
    Fuzzell L; Brownstein NC; Fontenot HB; Lake PW; Michel A; Whitmer A; Rossi SL; McIntyre M; Vadaparampil ST; Perkins RB
    Elife; 2023 Sep; 12():. PubMed ID: 37656169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
    Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Whitmer A; Michel A; McIntyre M; Rossi SL; Kajtezovic S; Vadaparampil ST; Perkins R
    Elife; 2023 Sep; 12():. PubMed ID: 37664989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
    Elife; 2023 Jun; 12():. PubMed ID: 37377399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
    Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
    Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
    BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Colposcopy: Indications and Risk Assessment.
    Burness JV; Schroeder JM; Warren JB
    Am Fam Physician; 2020 Jul; 102(1):39-48. PubMed ID: 32603071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
    Burger EA; Jansen EE; Killen J; Kok IM; Smith MA; Sy S; Dunnewind N; G Campos N; Haas JS; Kobrin S; Kamineni A; Canfell K; Kim JJ
    J Med Screen; 2021 Jun; 28(2):213-216. PubMed ID: 33730899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of COVID-19 Pandemic on Screening Programs for Cervical Cancer Prevention Across Europe.
    Carcopino X; Cruickshank M; Leeson S; Redman C; Nieminen P
    J Low Genit Tract Dis; 2022 Jul; 26(3):219-222. PubMed ID: 35533257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic.
    Delli Carpini G; Giorgi Rossi P; Giannella L; Di Giuseppe J; Clemente N; Sopracordevole F; Barbero M; Bogani G; De Vincenzo R; Origoni M; Cantatore F; Gardella B; Dominoni M; Monti E; Liverani CA; Viscardi A; Pagan A; Amadori A; Alessi C; Andolfatto M; Cattani P; Pieralli A; Stevenazzi G; Ciavattini A
    J Gynecol Oncol; 2023 Jan; 34(1):e7. PubMed ID: 36245226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of the Colposcopically Directed Punch Biopsy in Clinical Practice: A Survey of British Society of Colposcopy and Cervical Pathology (BSCCP)-Accredited Colposcopists.
    Myriokefalitaki E; Redman CW; Potdar N; Pearmain P; Moss EL
    J Low Genit Tract Dis; 2016 Jul; 20(3):234-8. PubMed ID: 27243143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.
    Jach R; Mazurec M; Trzeszcz M; Zimmer M; Kedzia W; Wolski H
    Ginekol Pol; 2021; 92(2):165-173. PubMed ID: 33751524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Decker KM; Musto G; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Feely A; Galloway K; Lambert P
    Technol Cancer Res Treat; 2024; 23():15330338241263616. PubMed ID: 39053019
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of COVID-19 on the cervical screening programme within a Northern Irish Health and Social care trust.
    McMullan JC; Rainey L; Morgan D; Johnston L
    Ulster Med J; 2023 May; 92(2):84-88. PubMed ID: 37649920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosing the results of the invasive cervical cancer review to patients: a survey of lead colposcopists across England.
    Sherman SM; Nailer E; Pearmain P; Todd RW; Redman CW
    Cytopathology; 2016 Aug; 27(4):237-41. PubMed ID: 26566859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Welsh cervical screening programme learning as a consequence of the coronavirus pandemic.
    Leeson S; Evered A; Powell G; Lilly K; Singh N; Hillier S; Dunk L
    Cytopathology; 2022 May; 33(3):350-356. PubMed ID: 34935223
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.